Regulatory (Re-)Scheduling of CBD & its Drug Abuse Liability

Regulatory (Re-)Scheduling of CBD & its Drug Abuse Liability (DAL)

Listen now

Description

In September 2018, the Drug Enforcement Agency (“DEA”) placed Epidiolex—a CBD-based drug used to treat severe forms of epilepsy—in Schedule V of the Controlled Substances Act (“CSA”), the lowest classification under the CSA. That re-scheduling, however, was limited in scope: only drugs approved by the Food and Drug Administration (“FDA”) and containing no more than…

More Episodes

See all »

CBD vs. THC

With CBD taking center stage this year, there has been increased coverage of this “miracle” compound in the news. But it’s important to remember that THC is also a very important cannabinoid with some very powerful properties. While many enjoy the calming benefits of CBD without the psychoactive...

Published 08/27/19

Biotechnology in the Manufacturing & Production of CBD

One of the greatest results of cannabis legalization has been the implantation of current methods and technology from the scientific sector into the cannabis industry. That technology and human talent has driven great strides in cannabinoid production. One has been the incorporation of CBD into a...

Published 08/26/19

A Brief History of Cannabis & The Legalization of Hemp

Cannabis policy changes are moving quickly throughout the US. With the passing of recent hemp legislation, members of the cannabis industry have a lot to look forward to this year, including state-by-state cannabis legalization. However, to better prepare for the future, it’s important to take a...

Published 08/26/19